8% Off
Thymoglobulin25 mg/10 m
Synovia Pharma PLC
৳19780.00
Add to cart
Generic medicine
Anti-Thymocyte Globulin: Brands, Price & Uses in Bangladesh
Anti-Thymocyte Globulin is a polyclonal antibody preparation with established and guideline-supported uses in transplantation and hematology: Prevention of acute rejection in renal transplant…
About Anti-Thymocyte Globulin
Indications of Anti-Thymocyte Globulin
Anti-Thymocyte Globulin is a polyclonal antibody preparation with established and guideline-supported uses in transplantation and hematology:
- Prevention of acute rejection in renal transplant patients, used as part of an immunosuppressive regimen in conjunction with corticosteroids and other immunosuppressants (established/approved use).
- Treatment of acute renal transplant rejection in conjunction with concomitant immunosuppression, typically when rejection is steroid-resistant (established/approved use).
- Treatment of moderate to severe aplastic anemia, particularly in patients who are not candidates for bone marrow/stem cell transplantation, usually combined with cyclosporine (established/approved use, product-specific).
- Off-label uses (guideline-supported in specialist practice but not universally labeled): induction immunosuppression and graft-versus-host disease (GVHD) prophylaxis in allogeneic hematopoietic stem cell transplantation, and induction therapy in other solid organ transplants (e.g., heart, liver, lung, pancreas).
Anti-Thymocyte Globulin must be prescribed and administered only by physicians experienced in immunosuppressive therapy and management of transplant/hematology patients.
Dosage & Administration of Anti-Thymocyte Globulin
| Indication | Typical Adult Dosing |
|---|---|
| Prevention of renal transplant rejection | Approximately 1–1.5 mg/kg/day by slow IV infusion for 4–7 days, per specific product labeling and institutional protocol |
| Treatment of acute renal transplant rejection | Approximately 1.5 mg/kg/day by slow IV infusion for 7–14 days, per specific product labeling |
| Aplastic anemia | Dose and duration vary by product (rabbit- vs equine-derived); administered as a multi-day IV infusion course, generally in combination with cyclosporine, per specific product labeling |
Exact dose, infusion rate, and duration depend on the specific commercial product (rabbit-derived or equine-derived) and must follow that product's approved labeling and the treating center's transplant/hematology protocol. Anti-Thymocyte Globulin is given by slow intravenous infusion (typically over 4–6 hours or longer) through a central line where possible, with continuous cardiac and vital sign monitoring, especially during the first dose.
Premedication
Premedication with corticosteroids, antihistamines, and/or antipyretics before each infusion is standard practice to reduce the risk of infusion-related and cytokine-release reactions. A test dose or slow initial infusion rate is used for the first dose in many protocols.
Side Effects of Anti-Thymocyte Globulin
Adverse effects of Anti-Thymocyte Globulin are frequent, particularly with the first infusion, and require close monitoring:
- Infusion-related/cytokine-release reactions: fever, chills, rigors, hypotension or hypertension, dyspnea, nausea, and in severe cases anaphylaxis (see Precautions).
- Hematologic: thrombocytopenia and leukopenia (common, usually reversible; requires regular blood count monitoring).
- Serum sickness: fever, rash, arthralgia, and lymphadenopathy occurring days to weeks after administration, related to the foreign (animal) protein content.
- Infections: increased susceptibility to bacterial, viral (including CMV and other opportunistic viral reactivation), fungal, and other opportunistic infections due to immunosuppression.
- Malignancy: increased long-term risk of malignancy, including post-transplant lymphoproliferative disease (PTLD), with prolonged or repeated immunosuppression.
- Other: local injection-site reactions, headache, myalgia, diarrhea, and elevated liver enzymes have been reported.
Contraindications of Anti-Thymocyte Globulin
Anti-Thymocyte Globulin is contraindicated in patients with:
- Known hypersensitivity to Anti-Thymocyte Globulin or to any component of the specific product, including hypersensitivity to rabbit or equine proteins/immunoglobulins (depending on the animal source of the specific product used).
Active, uncontrolled systemic infection is also considered an important contraindication by most product labels given the profound immunosuppression produced; treating physicians should confirm the specific product's full contraindication list before use.
Frequently Asked Questions about Anti-Thymocyte Globulin
What is Anti-Thymocyte Globulin used for?
Anti-Thymocyte Globulin is used to prevent and treat acute rejection after organ transplantation (such as kidney transplant) and to treat moderate to severe aplastic anemia, usually in combination with other immunosuppressive medicines.
How is Anti-Thymocyte Globulin given?
Anti-Thymocyte Globulin is given only as a slow intravenous infusion in a hospital, under close medical supervision, typically over several hours per dose and for a course of several days. It cannot be self-administered at home.
What are the most serious risks of Anti-Thymocyte Globulin?
The most serious risks include severe allergic (anaphylactic) reactions, especially with the first dose, low blood counts (thrombocytopenia and leukopenia), serious infections due to a weakened immune system, and a long-term increased risk of certain cancers, including lymphoma-related disorders. Because of these risks, Anti-Thymocyte Globulin is given only by physicians experienced in immunosuppressive therapy in a facility able to manage severe reactions.
Can Anti-Thymocyte Globulin be used during pregnancy?
Anti-Thymocyte Globulin should be used during pregnancy only if clearly needed and the potential benefit justifies the potential risk to the fetus, and only under close specialist supervision; a physician should be consulted before use.
Is Anti-Thymocyte Globulin safe for children?
Safety and efficacy in children have not been as extensively established as in adults, but Anti-Thymocyte Globulin is used off-label in specialized pediatric transplant/hematology centers with weight-based dosing and close monitoring.
What monitoring is needed while receiving Anti-Thymocyte Globulin?
Patients receiving Anti-Thymocyte Globulin require continuous monitoring of vital signs during each infusion, regular complete blood counts to detect thrombocytopenia or leukopenia, and monitoring for signs of infection, allergic reaction, or serum sickness (fever, rash, joint pain) for days to weeks after treatment.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.